Open access
Jul 2026
Pan-cancer analysis identifies KANSL2 as a cell-cycle–associated regulator of tumor progression and immunity in liver hepatocellular carcinoma
KANSL2 is identified as a key regulator of tumor progression and immune remodeling in LIHC and represents a promising biomarker for diagnosis and prognosis, and a potential therapeutic target.
Nan-Bin Liu, Kun Li, Jun-Qiao Feng et al.
· Clinical and Experimental Me... · 0 citations